4//SEC Filing
SYNTA PHARMACEUTICALS CORP 4
Accession 0001179110-15-010914
$MDGLCIK 0001157601operating
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 4:34 PM ET
Size
8.7 KB
Accession
0001179110-15-010914
Insider Transaction Report
Form 4
REARDON WILLIAM S
Director
Transactions
- Award
Common Stock
2015-07-01+5,681→ 47,120 total - Award
Common Stock
2015-07-01+2,272→ 49,392 total - Award
Director Stock Option (Right to Buy)
2015-07-01+20,000→ 20,000 totalExercise: $2.20Exp: 2025-07-01→ Common Stock (20,000 underlying)
Footnotes (3)
- [F1]Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 25% of the shares on each of September 30, 2015, December 31, 2015, March 31, 2016 and June 30, 2016, provided the Reporting Person continues to serve as a director of the Issuer on such date.
- [F2]Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 25% of the shares on each of September 30, 2015, December 31, 2015, March 31, 2016 and June 30, 2016, provided the Reporting Person continues to serve as Chairman of the Audit Committee of the Board of Directors of the Issuer on such date.
- [F3]The option vests as to 25% of the shares on each of September 30, 2015, December 31, 2015, March 31, 2016 and June 30, 2016, provided the Reporting Person continues to serve as a director of the Issuer on such date.
Documents
Issuer
SYNTA PHARMACEUTICALS CORP
CIK 0001157601
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001157601
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 4:34 PM ET
- Size
- 8.7 KB